| (EUR) | Dec 2024 | Y/Y change |
|---|---|---|
| Revenue | 19.00K | — |
| Operating expense | — | — |
| Net income | 0.00 | -100.00% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ALTME.PA returned +26.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +111.0% |
| 1 year | +26.2% |
| 5 years | -99.5% |
| All-time high | €1,993.31 (Dec 2016) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in ALTME.PA would be worth today ›No. TME Pharma N.V. has not paid a dividend in the past 12 months.
TME Pharma N.V. is part of the Healthcare sector.
TME Pharma N.V. has a market cap of 12.96M EUR, based on the latest quote.
